Vomiting, diarrhea, constipation, indigestion, abdominal discomfort, and decreased appetite have also been reported in retatrutide research
Overall, 36 percent of employers are providing GLP-1 coverage for both diabetes and weight loss (up from 34 percent in 2024)
It helps reduce visceral fat, improves insulin sensitivity, and directly modulates immune cell function, fostering an anti-inflammatory environment
Jens Juul Holst , a professor of medical physiology at the University of Copenhagen, is the man who made gut hormones famous world-wide
Mounjaro, on the other hand, received FDA approval in 2022 solely for the treatment of type 2 diabetes
[10] [11] A direct causal link with retatrutide has not yet been formally established, but the risk cannot be excluded Right upper quadrant pain, fever, or jaundice (yellowing of the skin or eyes), which may suggest gallbladder disease (such as gallstones or cholecystitis) another recognised class-related risk Severe constipation with vomiting, abdominal distension, and inability to pass wind, which may indicate intestinal obstruction or ileus and requires urgent assessment Symptoms that feel disproportionate or different in character from typical digestive upset In an emergency, contact NHS 111 or attend your nearest accident and emergency department
